Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response-Reference-Cited by-同舟云学术

Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response

Published:2006-11 Issue:9 Volume:26 Page:1079-1086
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Hung Chao-Hung,Lee Chuan-Mo,Lu Sheng-Nan,Wang Jing-Houng,Chen Chien-Hung,Hu Tsung-Hui,Kee Kwong-Ming,Chang Kuo-Chin,Tseng Po-Lin,Yen Yi-Hao,Changchien Chi-Sin

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2006.01354.x/fullpdf

Reference22 articles.

1. Epidemiology of Hepatitis C in the West

2. Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis

3. Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

4. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis

5. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin;Journal of the Formosan Medical Association;2020-01

2. Predictors of adverse drug reactions associated with ribavirin in direct‐acting antiviral therapies for chronic hepatitis C;Pharmacoepidemiology and Drug Safety;2019-11-06

3. Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA Genotype;Therapeutic Drug Monitoring;2019-08

4. Assessment of efficacy and safety of PEGylated interferon plus ribavirin in elderly patients with chronic hepatitis C;Advances in Digestive Medicine;2018-09

5. Urgency to treat patients with chronic hepatitis C in Asia;Journal of Gastroenterology and Hepatology;2017-04-27